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The conventional method for the axillary artery insertion of Impella 5.0 is a nontunneling route of the side-graft. We present an alternative technique in order to
facilitate device insertion and to ensure protection from potential wound
contamination. The technique consists of exiting the graft separately and away
from the main incision with an intact skin and subcutaneous fat between the two
sites. By proper isolation of the main wound, the risk of infection can thus be
largely mitigated. Furthermore, this technique allows a better landing entry angle of
graft insertion; the resulting smoother curve trajectory leads to facile device
insertion, while the risk of kinking after resumption of flow is readily avoided. A
further possible advantage would be a less likely to produce thrombosis at the
anastomosis. Differences of this technique have already been reported for
insertions of extracorporeal membrane oxygenation (ECMO), and for aortic
dissections and aneurysms. Our experience in 8 cases suggests the applicability
of our method to access the axillary artery for Impella 5.0 insertion.
Keywords: arterial cannulation, axillary artery, mechanical circulatory support,
axial flow left ventricular-aortic pump (Impella 5.0).

Introduction
Utilization of temporary (< 6 days)mechanical circulatory left ventricular (LV) assist
devices has allowed circulatory support and recovery of the LV in the treatment of
cardiogenic shock, or in the setting of acute left heart failure. In that regard, the
use of Impella 5.0 ventricular support system (Abiomed Inc., Danvers, MA) is
rapidly expanding; however, on occasion the LV recovery requires the device to be
in place for longer-time period where wound infection may be a problem. 1, 2
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Relevant technical steps
After confirmation of a suitable candidate, anesthesia is induced, a
transesophageal echo probe positioned, and a pulmonary central catheter is
introduced into the pulmonary artery. We prefer to perform the implantation in the
hybrid operating room.
Prior to procedure, ultrasound imaging is a key investigation of the axillary artery
that allows safe feasibility of a peripheral access, Figures 1A, B. This artery should
have a minimum caliber of 6.20 mm which is needed for the Impella device’s
implantation to proceed. The operative field should include both infraclavicular and
groin regions exposed in case additional access is needed.

A

B
Figure 1 A, B. The right axillary artery sizing is done using a handheld
ultrasound (GE Healthcare LOGIQe, Milwaukee, WI), 5-12 MHZ frequency
conversion probe.
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The infraclavicular exposure of the axillary artery (AA) starts with locating the
coracoid process which can be felt easily under the skin. The coracoid process
marks the most lateral border of an approximately two inch skin incision inferior
and parallel to the clavicle. After opening the deep clavipectoral fascia, the tendon
of the pectoralis minor muscle is divided (partially or totally) near its insertion on
the coracoid process.
Blunt blades Adson Cerebellum (V Mueller, Franklin Lakes, NJ) Retractor are
cranked up for retraction of pectoralis major muscle, and a Karmody Vascular
Spring Retractor (V Mueller) is used for deeper axillary fat retraction.
Except for the sub-adventitial AA isolation, no sharp dissection is used once the
AA has been visualized to avoid any trauma to this delicate vessel and to the
brachial cords. Instead, a Kittner dissector (peanut) is used to gently tease-off the
local connective tissue surrounding the vessel. Most of the time, the AA is
pulseless in such patients who may be managed with extracorporeal LV support.
The nerves to the pectoralis major muscle are preserved to avoid subsequent
atrophy of this muscle. The thoracoacromial arterial branch (TA) of the AA marks
the medial border of the anastomosis. As is done in the femoral artery exposure,
small vessel tributaries are not cauterized but rather are ligated in continuity with
fine silk (4.0) ties or hemoclipped. These tributaries are often accompanied by
lymphatic channels which will not coagulate with the electric current and thus
might lead to the postoperative lymphatic leaks. At this point, the lateral and
medial brachial plexus cords are particularly vulnerable, and care should be taken
not to cut or injure them through excessive diathermy heat. The AA is freed
subadventitially and 2 retraction tapes are used to facilitate its exposure. A doublelooped tape can be placed so as to straddle the TA branch3. This not only controls
the branch but also prevents slippage. The other tape is placed distally to
accommodate a distance of at least 1.2 cm so that a 10 mm Hemashield Platinum
woven double velour vascular graft (MAQUET Cardiovascular LLC Wayne, NJ)
can be anastomosed in an end to side fashion.The access point is usually medial
to the origin of the lateral thoracic artery.
After administering intravenously 5 to 10,000 units of heparin, a small CooleyDerra clamp (V Mueller) tangential occlusion clamp or two straight or profunda
vascular clamps are applied across the artery between the snares. Then the AA is
incised longitudinally, and the end to side anastomosis is completed with 5.0
proline suture. After completion of the anastomosis, meticulous hemostasis is
imperative especially since these devices require postoperative heparinization.
The graft is tunneled out of the infraclavicular pocket by subcutaneous passage
and a small incision is carried out at the shoulder exit wound site about 2” away
from the main incision, Figures 2 A, B, C.
Keeping the side graft straight and aligned as it enters the shoulder area,
depending on the AA anatomic depth dictates, should result in a trajectory without
kink. The 23 Fr (6 cm long) peel-away introducer with hemostatic valve is inserted
over the catheter shaft into the graft, and secured with the graft lock.
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A

B
Figure 2 A, B, C. Intraoperative photographs
showing the right
axillary artery
cannulation after
completion of an end-toside anastomosis
through a 10-mm side
graft. The exit wound is
being prepared, with the
surgeon standing on the
right side of the patient.
C
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The device catheter is then carefully advanced into the left ventricle. At this stage,
the ACT is maintained around 200 seconds. The device is advanced into the left
ventricle loaded on a 0.035 inch guidewire with the use of both transesophageal
echocardiography and fluoroscopy guidance. When both a correct Impella catheter
position across the aortic valve and a pulsatile placement signal are documented,
the device is activated after removing the wire and the peel away introducer.
Thereafter, the repositioning sheath is advanced to the arteriotomy site.
The flow rate is ramped up to a maximum P-9 level. All the flows were satisfactory,
and the patients became hemodynamically stable. The trimmed graft flush under
the skin is then secured around the catheter using a heavy silk tie (#5). The 2
incisions are closed in layers and the skin is stapled. Antibiotic wound irrigation is
optional.

Explantation technique
Under general anesthesia the surgical areas included the entire chest, right deltoid
region and the right groin. The surgical areas are draped separately as a
preemptive way to avoid contamination at the time when the assistant surgeon
pulls out the device from under the sheaths. Systemic antibiotic was administered.
The old staples and anchoring skin sutures of the repositioning device were
removed and the incision was reopened using only blunt dissection to avoid new
tissue trauma. At this point the old Hemashield graft was exposed and vessel
looped for potential bleeding control. The old surgical fragments were removed,
and deep wound culture was taken. The area was copiously irrigated with
Bacitracin solution. The main wound was draped separately from the outer area
where the device has been anchored.
Under trans-esophageal echocardiography and keeping the pump running at ramp
2, the device was withdrawn so the tip of the sheath was just above the aortic
valve. After this step, the pump was shot off and the device was withdrawn
afterward the vessel loop was snugged around the graft for bleeding control. A
vascular TA 30 stapler was used to sever the graft just 1 cm above the axillary
anastomosis and it was hemostatic. Thrombotic morcels were retrieved from the
stump of the graft to avoid potential distal arm embolization. A representative
thrombus material was sent for pathology examination. The wound was again
irrigated with Bacitracin solution and closed in layers.
We have employed this technique for cardiogenic heart failure in 8 cases with
good success. Two cases were due to viral myocarditis, and two cases due to
postcardiotomy cardiogenic shock. The remaining cases were due to idiopathic
cardiomyopathy. In those patients who survived, the graft was excised between 4
and 30 days post LV assistance with a mean of 11 days. Despite perioperative
heparinization, there have been no bleeding or hematoma formation, therefore no
transfusions were required due to perioperative blood loss. Furthermore, there
were no wound infections, kinking, cannulation issues, or device malposition. The
mean age was 66 years (SD ± 14; range: 48-76, 2 females) with 2 deaths: 1 due to
septicemia related to sacral ulcers, and 1 to pneumonia. The mean pump flow was
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4.5 ± 0.4 L/min. The remaining characteristics and patient outcomes are outlined in
the table 1.

Table 1. Patient characteristics and postoperative outcomes

Case

Age

Sex

Diagnosis

1

76

M

2
Right
axillary
3
Left
axillary

76

M

76

M

Cardiogenic
shock,
STEMI
Cardiogenic
shock,
STEMI
Cardiogenic
shock,
STEMI

4

48

F

5

74

M

6

52

F

7

75

M

8

48

M

Viral
myocarditis
Cardiogenic
shock s/p
CABGx3
Decompensated
systolic HF
Decompensated
systolic HF
s/p CABGx4,
MVR, TV
repair
Cardiogenic
shock,
myocarditis

Anastomotic bleeding
No

Wound
Infection

Flouro
time
(min)

Pump
Flows
L/min

Days
on
Impella

Follow up

Death
<30
days

No

13.9

4.9

2

Y
(2d)

No

No

8.8

4.4

12

Right heart failure,
Died after Impella
RP placed
Removed, pump
thrombosis

No

6.8

4.5

12

Mitraclip placed
for mitral
regurgitation

Y
(23 d)

No

No
Enterobacter
bacteremia
(pneumonia)
No

7.5

3.6

15

N

No

No

17

4.5

9

D/C to quaternary
care, D/C LTACH
D/C Rehab

No

No

7.9

5.0

4

Heart transplant

N

No

No
Impella
removed for
bacteremia,
source:sacral
wound
No

3.8

4.5

30

Alive at 30 days

N

4.4

4.9

8

D/C home

N

No

N

N

CABG= coronary artery bypass , D/C = Discharged, HF= heart failure, LTACH=
Long term acute care hospital, MVR= mitral valve replacement, STEMI= ST
elevation myocardial infarction, TV=tricuspid valve

Discussion
The conventional placement of the axillary artery cannulation is a non-tunneling
technique. It was originally described by Sabick et al with a side graft and was
associated with low morbidity compared with cannulating the artery directly4,5.
However, in that report the cannulation was only used temporarily during the
operation as inflow for cardiopulmonary bypass.
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The main advantages to the tunneling technique compared to conventional
placement are the prevention of wound contamination, either in the immediate
postoperative period, or in the case of requiring longer-term circulatory support.
A report by Mastroianniet et al. indicates a wound infection rate of 7%, one case
(Methicillin resistant Staphylococcus aureus) in 14 patients using the conventional
technique.6 The incidence of bleeding from the arterial outflow graft as reported by
others was 17.3 % (14 patients) using an arterial inflow by a side graft sewn to the
axillary artery for extracorporeal membrane oxygenation support in a cohort of 308
patients.7
Furthermore, it is well known that patients in heart failure are prone to systemic
infection due to their compromised immune defense system.8 Based on that
notion, it is our belief that wound infection rates after mechanical circulatory
support device implantation is underreported.
The second advantage of this technique is a potential decrease in clot formation at
the anastomotic site between the graft and the recipient axillary artery. This is
based on a smoother landing site due to the tunneling, with less formation of eddy
current. This assertion should be verified in further studies.
The AA is chosen as the first choice implantation as opposed to other peripheral
access because it allows ambulation, and often times one or both groin vessels
may have already been used either for extracorporeal membrane oxygenation, or
for a temporary right or left ventricular support (Impella 2.5 or Impella CP) before
upgrading to Impella 5.0 implantation. Finally, the axillary artery is rarely calcified
or is involved in arteriosclerosis.
The graft length must be carefully judged following passage under the shoulder
subcutaneous tissue. Redundant graft, which leads to kinking, as well as
overstretching which leads to tension on suture line, must both be avoided.
Tunneling the graft into the operative field prior to performing the anastomosis may
limit the hand movement of the operating surgeon.
The mean axillary artery diameter in the adult human is 6.38 mm (median 6.2, SD:
1.57 mm), and this size is sufficient for a 21 Fr microaxial pump motor to be
introduced without difficulty in the majority of cases.10 An endovascular dilator
(Cook Medical, Bloomington, Indiana), or a Garret dilator 5-6 mm tip flexible shaft
(Piling surgical instruments, Morrisville, NC) may be used to predilate the vessel if
necessary, Figure 3 A, B. If one AA is small, some patients have asymmetrically
sized vessels; therefore, the other side can be checked. If still unable to insert then
convert to venoarterial extracorporeal membrane oxygenation.
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A

B
Figure 3 A, B. Photographs of Garret vascular dilator and the endovascular
dilator.
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